PHS30 Health Care Costs in Psoriatic Arthritis (PSA) Patients Newly Initiated on a Biologic Disease-Modifying Anti-Rheumatic Drug (DMARDS) or Methotrexate (MTX)
Nov 1, 2012, 00:00
10.1016/j.jval.2012.08.1803
https://www.valueinhealthjournal.com/article/S1098-3015(12)03516-4/fulltext
Title :
PHS30 Health Care Costs in Psoriatic Arthritis (PSA) Patients Newly Initiated on a Biologic Disease-Modifying Anti-Rheumatic Drug (DMARDS) or Methotrexate (MTX)
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(12)03516-4&doi=10.1016/j.jval.2012.08.1803
First page :
A523
Section Title :
Health Services
Open access? :
No
Section Order :
1295